Press releases

Reaching new heights

Reaching new heights

Origenis GmbH Announces Research Collaboration with U.S. Cancer Center

June 04, 2019 Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma...

4. Juni 20192 Min. Lesezeit

May 16, 2019 Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new...

16. Mai 20191 Min. Lesezeit

April 29, 2019 A multipart AI-based, drug discovery platform, optimizing compounds for specificity, efficacy, physiochemical properties,...

29. Apr. 20191 Min. Lesezeit